CTAD 2025 | The longitudinal associations between plasma p-tau217 and amyloid PET: ADNI and HABS-HD cohorts

Mahnaz Shekari, PhD, University of California, Berkeley, CA, discusses a study on the longitudinal associations between plasma p-tau217 and amyloid PET. The study included individuals from the ADNI (NCT00106899) and HABS-BD cohorts, and found that these two biomarkers show some level of variance longitudinally, and they are capturing different biological processes. This interview took place at the 18th Clinical Trials on Alzheimer’s Disease (CTAD) Conference in San Diego, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.